Speakers 2014

  • AGARWAL Kosh

    UK

      Presentation

    • Treatment of HCV cirrhosis and transplanted patients - Monday, January 13th 2014 - Interactive luncheons - Room 5

    View more
  • AGHEMO Alessio

    Italy

      Presentation

    • The long term impact of treatment on the outcome of liver disease? - Monday, January 13th 2014 - Interactive luncheons - Room 1

    View more
  • ANTY Rodolphe

    France

      Presentation

    • Traitement des patients rechuteurs et non-répondeurs (French speaking luncheon) - Tuesday, January 14th 2014 - Interactive luncheons - Room 7

    View more
  • ASSELAH Tarik

    France

      Presentation

    • State of the art lecture and Award (chairman) - Monday, January 13th 2014 - 08:45 - 09:15

    • Genotype 4 - Monday, January 13th 2014 - 11:30

    • Advantages of 2nd generation triple therapy - Monday, January 13th 2014 - 16:00

    • How to optimize treatment in G4 patients? (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 6

    View more
  • BEDOSSA Pierre

    France

      Presentation

    • Staging of fibrosis: liver biopsy or indirect markers? - Monday, January 13th 2014 - Interactive luncheons - Room 4

    View more
  • BELHADJ BRIK Najet

    Tunisia

      Presentation

    • Interféron ou analogue ? (French speaking luncheon) - Monday, January 13th 2014 - Interactive luncheons - Room 7

    View more
  • BENAZZOUZ Mustapha

    Morocco

      Presentation

    • Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon) (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 8

    View more
  • BENHAMOU Yves

    France

      Presentation

    • Treat now - Monday, January 13th 2014 - 17:15

    • Future therapeutic strategies with direct acting antivirals (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 5

    View more
  • BERG Thomas

    Germany

      Presentation

    • Triple therapy with telaprevir or boceprevir: management of side effects - Tuesday, January 14th 2014 - Interactive luncheons - Room 4

    View more
  • BONINO Feruccio

    Italy

      Presentation

    • Optimal therapy of HBeAg-negative chronic hepatitis B (chairman) - Tuesday, January 14th 2014 - 11:30 - 12:30

    View more
    • Presentation

    • Personalized treatment with boceprevir - Monday, January 13th 2014 - 09:30

    View more
  • BOYER Nathalie

    France

      Presentation

    • Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon) (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 8

    View more
  • BRONOWICKI Jean-Pierre

    France

      Presentation

    • Traitement des patients rechuteurs et non-répondeurs (French speaking luncheon) (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 7

    View more
  • BRUNETTO Maurizia

    Italy

      Presentation

    • Clinical applications of HBsAg quantification (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 3

    • HBsAg quantitation : useful for staging the liver disease? - Tuesday, January 14th 2014 - 09:10

    View more
    • Presentation

    • Patients with cirrhosis - Monday, January 13th 2014 - 14:30

    View more
  • BUTI FERRET Maria

    Spain

      Presentation

    • Why do I treat my patient with a NUC? - Tuesday, January 14th 2014 - 10:30

    • How to manage relapsers and non-responders to PEG IFN + RBV therapy? - Tuesday, January 14th 2014 - Interactive luncheons - Room 3

    View more
  • CADRANEL Jean-François

    France

      Presentation

    • Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon) (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 8

    View more
  • CARDOSO Ana Carolina

    Brazil

      Presentation

    • Staging of fibrosis: liver biopsy or indirect markers? - Monday, January 13th 2014 - Interactive luncheons - Room 4

    View more
  • CASTERA Laurent

    France

      Presentation

    • Are non-invasive markers of fibrosis reliable? - Tuesday, January 14th 2014 - 08:55

    View more
  • CHAN Henry

    Hong Kong

      Presentation

    • Clinical applications of HBsAg quantification (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 3

    • The control of HBV related liver disease (chairman) - Tuesday, January 14th 2014 - 08:40 - 10:00

    View more
  • COLOMBO Massimo

    Italy

      Presentation

    • First line therapy: interferon or analogues? (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 2

    • Impact of HBV therapy on the incidence of hepatocellular carcinoma - Tuesday, January 14th 2014 - 14:45

    View more
  • CRAXI Antonio

    Italy

      Presentation

    • Regression of fibrosis. Is cirrhosis reversible? - Tuesday, January 14th 2014 - 08:40

    • How to optimize treatment in G1 naive patients? (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 1

    View more
  • DE LEDINGHEN Victor

    France

      Presentation

    • Staging of fibrosis: liver biopsy or indirect markers? (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 4

    View more
  • DEBZI Nabil

    Algeria

      Presentation

    • Comment optimiser le traitement des malades naïfs ? (French speaking luncheon) - Tuesday, January 14th 2014 - Interactive luncheons - Room 8

    View more
  • DELFRAISSY Jean-François

    France

      Presentation

    • ANRS: perspectives for basic research in viral hepatitis - Monday, January 13th 2014 - 08:45

    View more
  • DHUMEAUX Daniel

    France

      Presentation

    • Comment optimiser le traitement des malades naïfs ? (French speaking luncheon) (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 8

    View more
  • DI MARTINO Vincent

    France

      Presentation

    • Comment optimiser le traitement des malades naïfs ? (French speaking luncheon) - Tuesday, January 14th 2014 - Interactive luncheons - Room 8

    View more
    • Presentation

    • HIV-HCV coinfections (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 6

    • HIV co-infected patients - Monday, January 13th 2014 - 15:00

    View more
  • DURAND François

    France

      Presentation

    • Special populations (chairman) - Monday, January 13th 2014 - 14:30 -15:45

    View more
  • ESTEBAN Rafael

    Spain

      Presentation

    • Triple therapy with telaprevir or boceprevir: management of side effects (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 4

    • When to stop NUCs? - Tuesday, January 14th 2014 - 15:00

    View more
  • FERENCI Peter

    Austria

      Presentation

    • How to manage relapsers and non-responders to PEG IFN + RBV therapy? (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 3

    View more
  • FLISIAK Robert

    Poland

      Presentation

    • Controversy: F1/F2 patients: treat or wait? (chairman) - Monday, January 13th 2014 - 17:15

    • Triple therapy with telaprevir or boceprevir: management of side effects - Tuesday, January 14th 2014 - Interactive luncheons - Room 4

    View more
  • FOSTER Graham

    UK

      Presentation

    • Personalized treatment with telaprevir - Monday, January 13th 2014 - 09:15

    • How to optimize current therapy of non G1 patients (chairman) - Monday, January 13th 2014 - 11:00 - 12:00

    View more
    • Presentation

    • The long term impact of treatment on the outcome of liver disease? (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 1

    • Optimal therapy of HBeAg-positive chronic hepatitis B (chairman) - Tuesday, January 14th 2014 - 10:30 - 11:30

    View more
    • Presentation

    • Genotype 2 - Monday, January 13th 2014 - 11:00

    View more
  • HALFON Philippe

    France

      Presentation

    • Resistance to DAAs: is this a real issue? - Tuesday, January 14th 2014 - Interactive luncheons - Room 2

    View more
  • HEZODE Christophe

    France

      Presentation

    • Traitement des patients rechuteurs et non-répondeurs (French speaking luncheon) (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 7

    View more
  • HORBAN Andrzej

    Poland

      Presentation

    • How to manage relapsers and non-responders to PEG IFN + RBV therapy? (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 3

    View more
  • ISAKOV Vasily

    Russia

      Presentation

    • How to optimize treatment in G1 naive patients? - Tuesday, January 14th 2014 - Interactive luncheons - Room 1

    View more
    • Presentation

    • How to optimize current therapy of G1 patients (chairman) - Monday, January 13th 2014 - 09:15 - 10:30

    • HIV-HCV coinfections (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 6

    View more
  • JIA Ji Dong

    China

      Presentation

    • Optimal therapy of HBeAg-positive chronic hepatitis B (chairman) - Tuesday, January 14th 2014 - 10:30 - 11:30

    View more
  • KAO Jia-Horng

    Taiwan

      Presentation

    • Why do I treat my patient with pegylated IFN? - Tuesday, January 14th 2014 - 10:45

    View more
  • LADA Olivier

    France

      Presentation

    • Resistance to DAAs: is this a real issue? - Tuesday, January 14th 2014 - Interactive luncheons - Room 2

    View more
  • LAMPERTICO Pietro

    Italy

      Presentation

    • Why do I treat my patient with a NUC? - Tuesday, January 14th 2014 - 11:30

    View more
  • LAU George

    Hong Kong

      Presentation

    • First line therapy: interferon or analogues? - Monday, January 13th 2014 - Interactive luncheons - Room 2

    • New therapeutic perspectives (chairman) - Tuesday, January 14th 2014 - 14:30 - 16:30

    View more
  • LEE Sam

    Canada

      Presentation

    • Staging of fibrosis: liver biopsy or indirect markers? (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 4

    • Special populations (chairman) - Monday, January 13th 2014 - 14:30 -15:45

    View more
  • LEROY Vincent

    France

      Presentation

    • How to optimize treatment in G4 patients? - Tuesday, January 14th 2014 - Interactive luncheons - Room 6

    View more
  • LEVRERO Massimo

    Italy

      Presentation

    • Future therapeutic strategies with direct acting antivirals (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 5

    View more
    • Presentation

    • New interferons and immunomodulators - Tuesday, January 14th 2014 - 14:30

    View more
  • LIM Seng Gee

    Singapour

      Presentation

    • Optimal therapy of HBeAg-negative chronic hepatitis B (chairman) - Tuesday, January 14th 2014 - 11:30 - 12:30

    View more
  • MANNS Michael

    Germany

      Presentation

    • How to optimize current therapy of non G1 patients (chairman) - Monday, January 13th 2014 - 11:00 - 12:00

    View more
  • MARCELLIN Patrick

    France

      Presentation

    • Introduction: Treatment of hepatitis C: soon the end of the road ? - Monday, January 13th 2014 - 08:30

    • State of the art lecture and Award (chairman) - Monday, January 13th 2014 - 12:00 - 12:30

    • Conclusion - Monday, January 13th 2014 - 17:45

    • Introduction: HBV: Who, when and how to treat? (chairman) - Tuesday, January 14th 2014 - 08:30

    • Conclusion: tomorrow and after tomorrow? - Tuesday, January 14th 2014 - 15:45

    View more
  • MARTINOT-PEIGNOUX Michelle

    France

      Presentation

    • HBsAg quantitation : useful for the indication and follow-up of therapy ? - Tuesday, January 14th 2014 - 09:25

    View more
  • MATHURIN Philippe

    France

      Presentation

    • Resistance to DAAs: is this a real issue? (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 2

    View more
    • Presentation

    • New therapeutic strategies (chairman) - Monday, January 13th 2014 - 16:00 - 17:15

    View more
  • OMATA Masao

    Japan

      Presentation

    • How to optimize current therapy of G1 patients (chairman) - Monday, January 13th 2014 - 09:15 - 10:30

    View more
  • OULD GOUGAM Rachid

    Algeria

      Presentation

    • Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon) - Monday, January 13th 2014 - Interactive luncheons - Room 8

    View more
  • OUZAN Denis

    France

      Presentation

    • Clinical applications of HBsAg quantification - Monday, January 13th 2014 - Interactive luncheons - Room 3

    View more
  • PAIS Raluca

    France

      Presentation

    • Traitement des patients rechuteurs et non-répondeurs (French speaking luncheon) - Tuesday, January 14th 2014 - Interactive luncheons - Room 7

    View more
  • PAPATHEODORIDIS Georgios

    Greece

      Presentation

    • Why do I treat my patient with pegylated IFN? - Tuesday, January 14th 2014 - 11:45

    View more
  • PARANA FILHO Raymundo

    Brazil

      Presentation

    • How to manage relapsers and non-responders to PEG IFN + RBV therapy? - Tuesday, January 14th 2014 - Interactive luncheons - Room 3

    View more
  • PECK RADOSAVLJEVIC Markus

    Austria

      Presentation

    • Triple therapy with telaprevir or boceprevir: management of side effects (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 4

    View more
  • PETERSEN Jorg

    Germany

      Presentation

    • First line therapy: interferon or analogues? - Monday, January 13th 2014 - Interactive luncheons - Room 2

    View more
  • PIRATVISUTH Teerha

    Thailand

      Presentation

    • First line therapy: interferon or analogues? (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 2

    View more
  • POL Stanislas

    France

      Presentation

    • Genotype 3 - Monday, January 13th 2014 - 11:15

    View more
  • POPESCU Adriana

    Romania

      Presentation

    • Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon) - Monday, January 13th 2014 - Interactive luncheons - Room 8

    View more
  • RATZIU Vlad

    France

      Presentation

    • How to optimize treatment in G1 naive patients? (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 1

    View more
    • Presentation

    • New therapeutic perspectives (chairman) - Tuesday, January 14th 2014 - 14:30 - 16:30

    View more
  • ROCKSTROH Juergen

    Germany

      Presentation

    • HIV-HCV coinfections - Monday, January 13th 2014 - Interactive luncheons - Room 6

    View more
  • SALMON Dominique

    France

      Presentation

    • HIV-HCV coinfections - Monday, January 13th 2014 - Interactive luncheons - Room 6

    View more
  • SAMUEL Didier

    France

      Presentation

    • Treatment of HCV cirrhosis and transplanted patients (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 5

    • Transplant patients - Monday, January 13th 2014 - 14:45

    View more
  • SAYEGH Raymond

    Lebanon

      Presentation

    • Interféron ou analogue ? (French speaking luncheon) - Monday, January 13th 2014 - Interactive luncheons - Room 7

    View more
  • SCHIFF Eugene

    USA

      Presentation

    • Controversy: F1/F2 patients: treat or wait? (chairman) - Monday, January 13th 2014 - 17:15

    View more
  • SCHINAZI Raymond

    USA

      Presentation

    • Protease, polymerase and NS5A inhibitors: what will be the wining combination? - Monday, January 13th 2014 - 16:15

    • Resistance to DAAs: is this a real issue? (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 2

    View more
  • SERFATY Lawrence

    France

      Presentation

    • Is there still a role for PEG IFN+RBV therapy? - Monday, January 13th 2014 - 09:45

    View more
  • SHIFFMAN Mitchell

    USA

      Presentation

    • Still wait - Monday, January 13th 2014 - 17:30

    View more
  • SOBESKY Rodolphe

    France

      Presentation

    • Treatment of HCV cirrhosis and transplanted patients - Monday, January 13th 2014 - Interactive luncheons - Room 5

    View more
  • SOGNI Philippe

    France

      Presentation

    • Interféron ou analogue ? (French speaking luncheon) (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 7

    View more
  • SULKOWSKI Mark

    USA

      Presentation

    • Do we still need ribavirin? - Monday, January 13th 2014 - 16:30

    • Future therapeutic strategies with direct acting antivirals - Tuesday, January 14th 2014 - Interactive luncheons - Room 5

    View more
  • TRAN Albert

    France

      Presentation

    • Clinical applications of HBsAg quantification - Monday, January 13th 2014 - Interactive luncheons - Room 3

    View more
  • TREPO Christian

    France

      Presentation

    • Milestones in viral hepatitis - Monday, January 13th 2014 - 12:00

    View more
  • URBANEK Petr

    Czech Republic

      Presentation

    • How to optimize treatment in G1 naive patients? - Tuesday, January 14th 2014 - Interactive luncheons - Room 1

    View more
  • VALLA Dominique

    France

      Presentation

    • Treatment of HCV cirrhosis and transplanted patients (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 5

    View more
  • VOICULESCU Mihai

    Romania

      Presentation

    • Comment optimiser le traitement des malades naïfs ? (French speaking luncheon) (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 8

    View more
  • WAKED Imam

    Egypt

      Presentation

    • How to optimize treatment in G4 patients? - Tuesday, January 14th 2014 - Interactive luncheons - Room 6

    View more
  • WEILAND Ola

    Sweden

      Presentation

    • Future therapeutic strategies with direct acting antivirals - Tuesday, January 14th 2014 - Interactive luncheons - Room 5

    View more
  • YAZDANPANAH Yazdan

    France

      Presentation

    • The long term impact of treatment on the outcome of liver disease? - Monday, January 13th 2014 - Interactive luncheons - Room 1

    View more
  • ZARSKI Jean-Pierre

    France

      Presentation

    • Interféron ou analogue ? (French speaking luncheon) (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 7

    View more
  • ZEUZEM Stefan

    Germany

      Presentation

    • The long term impact of treatment on the outcome of liver disease? (chairman) - Monday, January 13th 2014 - Interactive luncheons - Room 1

    • New therapeutic strategies (chairman) - Monday, January 13th 2014 - 16:00 - 17:15

    View more
  • ZHDANOV Konstantin

    Russia

      Presentation

    • How to manage relapsers and non-responders to PEG IFN + RBV therapy? (chairman) - Tuesday, January 14th 2014 - Interactive luncheons - Room 3

    View more
  • ZOULIM Fabien

    France

      Presentation

    • The control of HBV related liver disease (chairman) - Tuesday, January 14th 2014 - 08:40 - 10:00

    View more